Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
Yoshinaga Okugawa(Mie University Hospital), Ajay Goel(City of Hope), Hiroki Mitoma(Baylor University), Yuji Toiyama(Mie University), Koji Tanaka(Mie University), Takeshi Nagasaka(Okayama University), Shusuke Toden(Baylor University Medical Center), C. Richard Boland(University of California San Diego), Masato Kusunoki(Mie University), Yasuhiro Inoue(Mie University)
Cited by 148
Related Papers
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
Pathways of Colorectal Carcinogenesis
|Gastroenterology|2019|594
Molecular Classification and Correlates in Colorectal Cancer
|Journal of Molecular Diagnostics|2007|460
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324